Page last updated: 2024-09-03

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and bu 224

5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide has been researched along with bu 224 in 1 studies

Compound Research Comparison

Studies
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Trials
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Recent Studies (post-2010)
(5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide)
Studies
(bu 224)
Trials
(bu 224)
Recent Studies (post-2010) (bu 224)
730861027

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ali, I; Andurkar, SV; Bhalla, S; Gulati, A; Lee, H1

Other Studies

1 other study(ies) available for 5-(dimethylamino)-n-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide and bu 224

ArticleYear
Potentiation of oxycodone antinociception in mice by agmatine and BMS182874 via an imidazoline I2 receptor-mediated mechanism.
    Pharmacology, biochemistry, and behavior, 2013, Volume: 103, Issue:3

    Topics: Agmatine; Analgesics, Opioid; Animals; Benzofurans; Dansyl Compounds; Drug Synergism; Imidazoles; Imidazoline Receptors; Male; Mice; Oxycodone; Pain Measurement

2013